Neogenomics (NEO) Other financing activities (2012 - 2017)

Neogenomics (NEO) has 6 years of Other financing activities data on file, last reported at $368000.0 in Q4 2017.

• Quarterly Other financing activities rose 17.95% year-over-year to $368000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $2.6 million (down 31.37% YoY) and the FY2018 annual result came in at $144.1 million, up 5472.08% from the prior year.
• Other financing activities fell to $368000.0 in Q4 2017, from $1.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.3 million in Q3 2014 to a low of $109000.0 in Q1 2015.
• A 5-year average of $589823.5 and a median of $505000.0 in 2017 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2015 — Other financing activities slumped 83.53% — and 2016, when it surged 1090.83%.
• Tracing NEO's Other financing activities over 5 years: stood at $122000.0 in 2013, then soared by 322.95% to $516000.0 in 2014, then tumbled by 34.88% to $336000.0 in 2015, then retreated by 7.14% to $312000.0 in 2016, then climbed by 17.95% to $368000.0 in 2017.
• The last three Other financing activities figures came in at $368000.0 (Q4 2017), $1.0 million (Q3 2017), and $671000.0 (Q2 2017), per Business Quant data.